Ohtomo K, Furui S, Kokubo T, Yamauchi T, Itai Y, Yashiro N, Iio M
Radiat Med. 1985 Jul-Sep;3(3):176-80.
Among 224 hepatomas treated with transcatheter arterial embolization, ten patients who survived for three years are presented. All cases had nodular lesions and the volume ratio of tumor to liver was less than 10% in nine cases. Eight cases had no large venous extension, however, one had 90% occlusion of the portal trunk and the other had tumor thrombus within the inferior vena cava. Laboratory data showed liver function was largely spared in eight cases, whereas the other two had severe liver cirrhosis. CT and/or angiography showed an increase in tumor volume in eight cases after three years of survival. Beneficial factors for long-term survival and the limitations of embolization are also discussed.
在224例接受经导管动脉栓塞治疗的肝癌患者中，报告了10例存活三年的患者。所有病例均有结节性病变，9例肿瘤与肝脏的体积比小于10%。8例无大静脉扩展，然而，1例门静脉主干闭塞90%，另1例下腔静脉内有肿瘤血栓形成。实验室数据显示，8例患者的肝功能基本得以保留，而另外2例有严重肝硬化。CT和/或血管造影显示，8例患者存活三年后肿瘤体积增大。还讨论了长期存活的有利因素以及栓塞治疗的局限性。
